Default Category
-
Embrace (B): Opportunity Assessment
Mridula Anand; Anand Nandkumar; Charles DhanarajCase IVEY-9B13M005-EEntrepreneurship, StrategyAWARD WINNING CASE - Indian Management Issues and Opportunities Award, 2013 European Foundation for Management Development (EFMD) Case Writing Competition. Part B of a four-part series, which also includes 9B13M004, 9B13M006 and 9B13M007.Starting at €5.74
-
Embrace (C): Competing with Incumbents
Mridula Anand; Anand Nandkumar; Charles DhanarajCase IVEY-9B13M006-EEntrepreneurship, StrategyAWARD WINNING CASE - Indian Management Issues and Opportunities Award, 2013 European Foundation for Management Development (EFMD) Case Writing Competition. Part C of a four-part series, which also includes 9B13M004, 9B13M005 and 9B13M007.Starting at €5.74
-
PerkinElmer - Developing Products in China for China
Sato, Vicki L.; Jaeker, Christoph; Reda, KareemCase HBS-612032-EService and Operations ManagementTo maximize their effectiveness, color cases should be printed in color. Sym-Bio, an entrepreneurial Chinese diagnostic company with a product line in infectious disease testing, has agreed to be acquired by PerkinElmer, an international corporation with businesses in neonatal testing, life science services, and environmental health. Sym-Bio wants to accelerate its growth and competitive position in China through this strategic move, and PerkinEl...Starting at €8.20
-
China Novartis Institute for Biomedical Research: Building a sustainable, globally integrated research enterprise, Teaching Plan
Sato, Vicki L.; Lobb, AnnelenaTeaching Note HBS-613103-ETeaching Plan for 612048.Starting at €0.00
-
Novartis in India: Innovation versus Affordability
Anand Nandkumar; Charles Dhanaraj; Mridula AnandCase IVEY-9B12M111-EStrategyThis case presents complex managerial challenges that stem from the institutional context in emerging markets, particularly in relation to the intellectual property regime and its impact on business strategy. The case centres around a multinational pharmaceutical firm, Novartis International AG (Novartis), that is waiting on a major court decision regarding patent policy as it pertains to one of the firm’s products. The case takes students throug...Starting at €8.20
-
Embrace (D): Building the Business Model
Mridula Anand; Anand Nandkumar; Charles DhanarajCase IVEY-9B13M007-EEntrepreneurship, StrategyAWARD WINNING CASE - Indian Management Issues and Opportunities Award, 2013 European Foundation for Management Development (EFMD) Case Writing Competition. Part D of a four-part series, which also includes 9B13M004, 9B13M005 and 9B13M006.Starting at €5.74
-
Embrace (A): Opportunity Identification
Mridula Anand; Anand Nandkumar; Charles DhanarajCase IVEY-9B13M004-EEntrepreneurship, StrategyAWARD WINNING CASE - Indian Management Issues and Opportunities Award, 2013 European Foundation for Management Development (EFMD) Case Writing Competition.The Embrace case series provides an engaging context to understand social innovation, by taking students through a sequence of critical decisions from opportunity analysis and market feasibility study to formulating a competitive strategy and developing business models for growth. The focus of ...Starting at €8.20
-
China Novartis Institute for Biomedical Research: Building a sustainable, globally integrated research enterprise
Sato, Vicki L.; Jaeker, Christoph; Solanki, Pooja MehtaCase HBS-612048-ETo maximize their effectiveness, color cases should be printed in color. As the head of the Novartis Institute for Biomedical Research in China, En Li was shepherding a $1 billion R&D investment in China. So far he had been able to attract a large number of Chinese-born but US-trained scientists to play a critical role in establishing the site. How sustainable was this strategy, and what were the key things he had to do right to establish a globa...Starting at €8.20
-
BMS-Biocon Research Center: Growing a Joint Research Venture in India
Sato, Vicki L.; Chai, Sen; Ballenger, Rich; Chi, Christine; Down, Alexander; Leimberg, RossCase HBS-613072-EEntrepreneurshipBristol Myers Squibb, a multi-national pharmaceutical company, is seeking to globalize its R&D strategy while managing costs. It has formed a joint venture with an Indian company, which has worked well, but now faces a strategic decision on how and whether to continue.Starting at €8.20